Untitled case

This case, IPR2025-01104, involves a patent validity challenge initiated by Unified Patents against U.S. Patent No. 12,011,329, owned by Ascentcare Dental Products Inc. and Solmetex LLC. Unified Patents is a member-based organization dedicated to deterring non-practicing entities (NPEs) from asserting questionable patents by challenging their validity, primarily through inter partes reviews (IPRs) at the Patent Trial and Appeal Board (PTAB). Ascentcare Dental Products Inc. and Solmetex LLC appear to be the patent owners for the challenged patent. While the IPR process itself does not directly involve an "accused product," the patent at issue, U.S. Patent No. 12,011,329, broadly relates to mechanical engineering, manufacturing, and products, specifically an intraoral device with anti-collapse and suction functionality.

The procedural posture of this case is an inter partes review before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office. Unified Patents filed its petition on June 7, 2025. The PTAB ultimately denied institution of the IPR on the merits on December 23, 2025. This particular denial is notable as it falls within a period, specifically starting October 20, 2025, when USPTO Director John Squires assumed personal control over all IPR and Post-Grant Review (PGR) institution decisions. This shift led to a significant increase in institution denials, often issued as summary notices without detailed reasoning, reflecting a new policy aiming for increased efficiency and consistency in the patent system. This case, being denied institution on the merits during this centralized decision-making period, exemplifies the impact of these policy changes at the PTAB.

PTAB Invalidity Challenge to U.S. Patent 12011329 Concludes with Non-Institution

The legal developments surrounding U.S. Patent 12011329 primarily involve an Inter Partes Review (IPR) proceeding, IPR2025-01104, before the Patent Trial and Appeal Board (PTAB). No related patent infringement litigation in a district court involving this specific patent has been identified in public records.

Key Legal Developments and Outcome:

Parallel PTAB IPR Proceeding:

• IPR Petition Filing: On June 7, 2025, Ascentcare Dental Products Inc. (as Petitioner) filed an Inter Partes Review petition, IPR2025-01104, challenging the validity of U.S. Patent 12011329. The patent is owned by Solmetex LLC.
• Non-Institution Decision: On December 23, 2025, the PTAB issued a decision denying institution of the IPR petition on the merits, meaning the Board determined that Ascentcare Dental Products Inc. did not demonstrate a reasonable likelihood of prevailing on at least one challenged claim.
• Context of Non-Institution: This decision occurred during a period (beginning October 2025) when USPTO Director John Squires assumed personal control over all IPR institution determinations. During this time, the Director issued numerous denials, often without extensive written reasoning, as part of a policy shift that aimed to strengthen patent rights. While the specific rationale for the "Not Instituted - Merits" decision in IPR2025-01104 was not detailed in broadly available public summaries, discussions around IPRs from this period, including IPR2025-01104, noted arguments related to potential "material errors" by patent examiners during original prosecution as a basis for challenging claims. Despite such arguments, the petition was ultimately not instituted.

Absence of District Court Litigation:

As of the current date (2026-05-19), no public records indicate any related patent infringement litigation in U.S. district courts involving U.S. Patent 12011329. Therefore, there are no developments regarding initial pleadings, pre-trial motions, claim construction, discovery, trial events, or appeals in a separate infringement case to report. The IPR proceeding served as the primary legal challenge to the patent's validity.

Unified Patents regularly engages both in-house counsel and external law firms to represent it in inter partes review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB). While the provided case metadata identifies Unified Patents as the plaintiff in IPR2025-01104, public PTAB data aggregated by Unified Patents itself lists Ascentcare Dental Products Inc. as the petitioner for IPR2025-01104 against U.S. Patent 12011329, with Solmetex LLC as the owner.

Given the instruction to treat the case metadata as authoritative, and assuming Unified Patents is the petitioner in this instance, the following attorneys are known to represent Unified Patents in PTAB IPR proceedings:

Unified Patents In-House Counsel (Senior Patent Counsel)

Unified Patents employs a dedicated team of in-house Senior Patent Counsel who are responsible for preparing and litigating post-grant proceedings before the PTAB. Their offices are typically based in Washington, D.C..

• Jordan Rossen
  • Role: Senior Patent Counsel, In-House
  • Firm: Unified Patents (Washington, D.C. office implied by company location)
  • Experience: Prior to joining Unified Patents, Rossen practiced in intellectual property litigation at Ropes & Gray and Paul Hastings in Washington, D.C., for eleven years, focusing on post-grant proceedings before the PTAB.
• David Seastrunk
  • Role: Senior Patent Counsel, In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Before Unified Patents, Seastrunk practiced at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, where he was involved in post-grant proceedings, district court cases, and International Trade Commission investigations, as well as patent prosecution and client counseling.
• Michelle Callaghan
  • Role: Senior Patent Counsel, In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Previously at Erise IP, Callaghan defended clients against patent demands in district courts, challenged patents before the PTAB, and prepared opinions on patent validity and infringement across various technologies including communication networks, video coding, virtual reality, and financial transaction security.
• Alyssa Holtslander
  • Role: Trademark Managing Counsel (previously Senior Patent Counsel), In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Prior to Unified Patents, Holtslander practiced at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP for over ten years, preparing and litigating post-grant proceedings.
• Jessica L.A. Marks
  • Role: SEP & Foreign Managing Counsel (previously Senior Patent Counsel), In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Marks spent over ten years at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, litigating post-grant proceedings, district court, and ITC cases, and is also experienced in licensing negotiations, patent prosecution, and due diligence.
• Jung Hahm
  • Role: Senior Patent Counsel, In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Before joining Unified Patents, Hahm practiced at Amster, Rothstein & Ebenstein LLP for over 16 years, focusing on PTAB trial practice, patent litigation, patent preparation and prosecution, and patent portfolio management.
• Kelly Hughes
  • Role: Senior Patent Counsel, In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Mentioned as in-house counsel representing Unified Patents in prior IPR proceedings.
• T.J. Murphy
  • Role: Senior Patent Counsel, In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Senior Patent Counsel for Unified Patents, involved in post-grant proceedings.
• Vinu Raj
  • Role: Senior Patent Counsel, In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Senior Patent Counsel for Unified Patents, involved in post-grant proceedings.
• Andrea Shoffstall
  • Role: Senior Patent Counsel, In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Senior Patent Counsel for Unified Patents, involved in post-grant proceedings.
• Jason Wejnert
  • Role: Senior Patent Counsel, In-House
  • Firm: Unified Patents (Washington, D.C. office implied)
  • Experience: Senior Patent Counsel for Unified Patents, involved in post-grant proceedings.

External Counsel

Unified Patents has also used external counsel for PTAB proceedings in the past. For example, in one IPR, Unified Patents was represented by attorneys from Haynes and Boone. It is common for them to leverage outside firms for specialized expertise or workload management.

• Haynes and Boone, LLP
  • Attorneys (example from a previous IPR): Jon Bowser, Angela Oliver, Michael McCarty, and Matt Beck (who later joined Unified Patents).
  • Experience: Known for robust patent litigation and PTAB practice.

Since the specific docket for IPR2025-01104 with Unified Patents as petitioner was not directly found, and the Unified Patents' portal lists Ascentcare Dental Products Inc. as the petitioner, the above list represents the attorneys typically involved in representing Unified Patents in their IPR challenges. The filings for IPR2025-01104 would specify the exact counsel who appeared in that particular proceeding.

Counsel for Patent Owner Solmetex LLC in IPR2025-01104

In IPR2025-01104, where Unified Patents is the petitioner, Solmetex LLC is the Patent Owner. Despite thorough searching of publicly available PTAB dockets and legal news databases, the specific counsel of record representing Solmetex LLC in this particular IPR proceeding has not been explicitly identified in the available search results. Therefore, the detailed information regarding individual attorneys, their roles, firms, and experience cannot be provided at this time. Filings for this case may not be publicly indexed with attorney information in the provided search results, or the information may be sealed.